Combination Antithrombotic Therapies

被引：93
作者：
Gurbel, Paul A. [1 ]
Tantry, Udaya S. [1 ]
机构：
[1] Sinai Hosp, Sinai Ctr Thrombosis Res, Cardiac Catheterizat Labs, Baltimore, MD 21215 USA
来源：
CIRCULATION | 2010年 / 121卷 / 04期
关键词：
platelets; thrombosis; coronary artery disease; aspirin; thienopyridine; bleeding; PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; ELEVATION MYOCARDIAL-INFARCTION; MAINTENANCE-DOSE CLOPIDOGREL; P2Y(12) RECEPTOR ANTAGONIST; ELUTING STENT IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; HIGH-RISK PATIENTS; PLATELET-AGGREGATION; DOUBLE-BLIND;
D O I：
10.1161/CIRCULATIONAHA.109.853085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：569 / 583
页数：15
相关论文
共 113 条
[51]   Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting [J].
Hashiguchi, M ;
Ohno, K ;
Nakazawa, R ;
Kishino, S ;
Mochizuki, M ;
Shiga, T .
CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (03) :211-217
[52]   A RANDOMIZED TRIAL COMPARING TICLOPIDINE HYDROCHLORIDE WITH ASPIRIN FOR THE PREVENTION OF STROKE IN HIGH-RISK PATIENTS [J].
HASS, WK ;
EASTON, JD ;
ADAMS, HP ;
PRYSEPHILLIPS, W ;
MOLONY, BA ;
ANDERSON, S ;
KAMM, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) :501-507
[53]   Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease - A meta-analysis of Randomized trials [J].
Helton, Thomas J. ;
Bavry, Anthony A. ;
Kumbhani, Dharam J. ;
Duggal, Sandeep ;
Roukoz, Henri ;
Bhatt, Deepak L. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (04) :289-297
[54]   Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review [J].
Hovens, Marcel M. C. ;
Snoep, Jaapjan D. ;
Eikenboom, Jeroen C. J. ;
van der Bom, Johanna G. ;
Mertens, Bart J. A. ;
Huisman, Menno V. .
AMERICAN HEART JOURNAL, 2007, 153 (02) :175-181
[55]   Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial [J].
James, Stefan ;
Akerblom, Axel ;
Cannon, Christopher P. ;
Emanuelsson, Hakan ;
Husted, Steen ;
Katus, Hugo ;
Skene, Allan ;
Steg, Philippe Gabriel ;
Storey, Robert F. ;
Harrington, Robert ;
Becker, Richard ;
Wallentin, Lars .
AMERICAN HEART JOURNAL, 2009, 157 (04) :599-605
[56]   Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity [J].
Jeong, Young-Hoon ;
Lee, Seung-Whan ;
Choi, Bong-Ryong ;
Kim, In-Suk ;
Seo, Myung-Ki ;
Kwak, Choong Hwan ;
Hwang, Jin-Yong ;
Park, Seong-Wook .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (13) :2009-1109
[57]   Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite [J].
Kazui, Miho ;
Nishiya, Yumi ;
Ishizuka, Tomoko ;
Hagihara, Katsunobu ;
Farid, Nagy A. ;
Okazaki, Osamu ;
Ikeda, Toshihiko ;
Kurihara, Atsushi .
DRUG METABOLISM AND DISPOSITION, 2010, 38 (01) :92-99
[58]   Peri-Procedural Platelet Function and Platelet Inhibition in Percutaneous Coronary Intervention [J].
Kereiakes, Dean J. ;
Gurbel, Paul A. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (02) :111-121
[59]   Translational therapeutics of dipyridamole [J].
Kim, Hyung-Hwan ;
Liao, James K. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (03) :S39-S42
[60]   Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention [J].
Kim, Jang-Young ;
Lee, Kyounghoon ;
Shin, Myungsang ;
Ahn, Minsoo ;
Choe, Hyunmin ;
Yoo, Byung-Su ;
Yoon, Junghan ;
Choe, Kyung-Hoon ;
Lee, Seung-Hwan .
CIRCULATION JOURNAL, 2007, 71 (12) :1867-1872
12345678910